ARBOR PHARMACEUTICALS LLC has a total of 25 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are REYNOLDS MAX, SCF PHARMA INC and SUKAMPO AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Medical technology | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Spring Nicholas | 5 |
#2 | Cundy Kenneth C | 5 |
#3 | Virsik Peter A | 5 |
#4 | Leung Manshiu | 4 |
#5 | Stach Paul E | 4 |
#6 | Kadri Balaji V | 4 |
#7 | Karaborni Sami | 4 |
#8 | Wustrow David J | 4 |
#9 | Gwozdz Garry T | 4 |
#10 | Sastry Srikonda | 4 |
Publication | Filing date | Title |
---|---|---|
US10342787B1 | Non-Aqueous Liquid Nimodipine Compositions | |
WO2015153762A1 | Sotalol compositions and uses of the same | |
WO2015073736A1 | Methods and compositions for treating adhd | |
AU2004274002A1 | Treating or preventing restless legs syndrome using prodrugs of GABA analogs |